HeyJaredSheena Meredith
- Indexed articles, last 90 days
- 34
- Latest publication
- Sep 29, 2026
- Outlet visibility, for Medscape
- Top 50K sites
- Earliest in this view
- Jul 10, 2026
Latest articles
Youth Mental Health Care Lagging Need, Charities Warn (opens the original)
Read excerpt
Mental health support for children and young people “is not keeping up with rising levels of need”, according to Future Minds, a coalition of children’s mental health charities. The Future Minds coalition, which includes the Centre for Young Lives and the Centre for Mental Health, said that over the Labour government's 2 years in power, no progress had been made on improving new access and waiting time standards for children and young people’s mental health services. Its 'mid-term report' verdic
SMC Extends SMA Drug Access to Newborns (opens the original)
Read excerpt
The Scottish Medicines Consortium (SMC) has accepted nusinersen (Spinraza, Biogen Idec) for restricted use within NHS Scotland to treat pre-symptomatic 5q spinal muscular atrophy (SMA), extending access to infants identified before symptoms develop, rather than only those already showing signs of the disease. The decision follows the rollout of routine newborn screening for SMA in Scotland, which now identifies affected infants before symptoms appear — a population for whom pre-symptomatic treat
Pharmacies Call for Tougher Response to Increasing Crime (opens the original)
Read excerpt
The National Pharmacy Association (NPA) is calling on the NHS and police to respond more robustly to what it says is escalating crime against pharmacies, warning that the current response is inadequate and disproportionate. The NPA represents around 6000 independent community pharmacies across the UK. While reports of thefts from pharmacies are part of a wider trend of escalating retail crime, shop thefts, and town centre antisocial behaviour, the NPA said that pharmacies were in a particularly
Controversial Drug Suspended Due to Trial Irregularities (opens the original)
Read excerpt
A review of the benefits and risks of avacopan (Avacopan Vifor) begun by the Medicines and Healthcare products Regulatory Agency (MHRA) in June has concluded that the available evidence no longer supports a positive benefit-risk balance for the drug, previously known by its US name Tavneos. The review was initiated following concerns about the “integrity and reliability” of data from the pivotal clinical study underpinning avacopan's licence authorisation. However, while expert commentary acknow
NHS Alliance Warns ADHD, Autism Costs Spiralling (opens the original)
Read excerpt
A “steep and relentless rise in demand” for ADHD and autism services in England has led to spiralling costs that are “running out of control,” according to the NHS Alliance. The alliance said that local health leaders were “keenly aware of the deep frustration felt” over long delays for assessment. However, unplanned overspends on ADHD and autism assessments and treatment impacted other activities and disrupted long-term planning. Some service providers reported being forced to close waiting lis
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Medscape, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.